Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study

Effects of COVID-19 infection in patients with autoimmune pulmonary alveolar proteinosis: a single-center study

Abstract Background Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare interstitial lung disease. COVID-19 is associated with worse prognosis in previous lung diseases patients. But the prognosis of aPAP patients after infection with COVID-19 is unclear. In December 2022, China experienced a...

Full description

Bibliographic Details
Main Authors: Chuanxin Duan, Wangji Zhou, Miaoyan Zhang, Chongsheng Cheng, Wenshuai Xu, Jinrong Dai, Shuzhen Meng, Keqi Chen, Yang Zhao, Song Liu, Shao-Ting Wang, Yanli Yang, Kai-Feng Xu, Xinlun Tian
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Autoimmune pulmonary alveolar proteinosis
COVID-19
Oxygen saturation
Online Access:https://doi.org/10.1186/s13023-023-02950-9

Internet

https://doi.org/10.1186/s13023-023-02950-9

Similar Items